Navigation Links
Amicus in Medical News

Retail Industry Leaders Association Files Amicus in California Health Care Litigation

ARLINGTON, Va., March 31 /PRNewswire/ -- The Retail Industry Leaders Association (RILA) today filed a friend-of-the-court (amicus) brief in litigation under consideration in the United States Court of Appeals for the Ninth Circuit challenging the City of San Francisco's employer health plan ma...

CMPI to Host Hill Briefing Tomorrow on Follow-on Biologic Drugs for Media and Congressional Staff With Reps. Eshoo and Rogers

...icer, Thomas Jefferson University, and Director, Jefferson Center for Vascular Diseases; and John F. Crowley, President and Chief Executive Officer of amicus Therapeutics. All three will help highlight the importance of balancing cost reduction and the well-being of patients in the follow-on biologics debat...

Americans United for Life: Ninth Circuit Ruling on Pharmacists Endangers Fundamental Freedoms

...ral, or ethical beliefs, it is a loss for liberty and undermines the Constitution itself." AUL assisted the plaintiffs' attorney in coordinating amicus brief support and also filed a brief on behalf of nineteen Washington Senators and Representatives, arguing that the U.S. Constitution and Supreme Co...

CMPI to Host Hill Briefing on Follow-On Biologic Drugs for Media and Congressional Staff with Reps. Eshoo and Rogers

...er, Thomas Jefferson University , and Director, Jefferson Center for Vascular Diseases; and John F. Crowley, President and Chief Executive Officer of amicus Therapeutics. All three will help highlight the importance of balancing cost reduction and the well-being of patients in the follow-on biologics debat...

Ohio Supreme Court Supports Regulation of Dangerous Abortion Drug

... decisive end to that." Americans United for Life (AUL) filed an amicus brief in the case on behalf of several U.S. Representatives supporting the State and the law. AUL's amicus brief, filed on behalf of House Minority Leader John Boehner (Ohio) and nin...

Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill'

... decisive end to that." Americans United for Life (AUL) filed an amicus brief in the case on behalf of several U.S. Representatives supporting the State and the law. AUL's amicus brief, filed on behalf of House Minority Leader John Boehner (Ohio) and nin...

Americans United for Life Applauds Fourth Circuit Protecting Women and Children by Upholding Virginia Partial Birth Abortion Statute

...at mirrors the federal ban on partial-birth abortion. Americans United for Life (AUL) provided litigation support to the state and filed an amicus brief supporting Virginia's law. In addition, AUL Senior Counsel Clarke Forsythe assisted the Solicitor General of the Commonwealth of Virginia wit...

LCA Hails US Court of Appeals Decision to Affirm Lower Court Ruling Tobacco Companies Guilty of Massive Fraud and Deception

...llow her to assess retrospective penalties. LCA joined in a subsequent amicus brief urging the appeals court to reconsider. That was denied in Friday's r...n low levels of federal research funding for lung cancer. The intent of the amicus brief was to make up for this short-fall. "Even though the Court rulin...

Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit

...his work with Celgene Corporation, Dr. Barer serves on the Board of Trustees of Rutgers University and BioNJ, on the Board of Directors of PhRMA and amicus Therapeutics, and on the Board of the Brooklyn College Foundation. He has previously served as a Commissioner of the NJ Commission on Science and Te...

Americans United for Life Represents 28 Bipartisan Montana Legislators Arguing Assisted Suicide Not a Right

...ountable. That is not assisted suicide--that is euthanasia." AUL worked in conjunction with the Montana Attorney General's office to coordinate amicus briefs supporting the State's current prohibition of assisted suicide. AUL's brief is available at http://tinyurl.com/Baxter-v-MT ...
Amicus in Medical Technology

Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease

...RANBURY, N.J., June 22 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced it ...s year. John F. Crowley, President and CEO of amicus stated, "The start of our Phase 3 trial with Amigal is a major milestone for amicus and highlights our transition into a late-stage de...

Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent

...CRANBURY, N.J., March 25 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced the...red by the standard endpoints in Gaucher disease. amicus previously reported that enrollment has been compl...to be available in the third quarter of 2009. amicus is developing Plicera as part of a strategic colla...

Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease

... CRANBURY, N.J., Feb. 27 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) announced today tha...rting the trial as expeditiously as possible. amicus initiated the Phase 2 clinical trial of AT2220 in ...0. After initial evaluation of the events, amicus suspended patient enrollment for the Phase 2 trial...

Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009

... CRANBURY, N.J., Jan. 12 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced pos...nt of Fabry disease in the second quarter of 2009. amicus also reviewed data on the potential for the combin...chloride) for the treatment of Fabry Disease amicus previously announced in August 2008 that it had co...

Amicus Therapeutics Announces Second Quarter 2008 Financial Results

... CRANBURY, N.J., Aug. 7 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ), a biopharmaceutical.... Generally Accepted Accounting Principles (GAAP), amicus announced a net loss attributable to common stockh...sease," said John F. Crowley, President and CEO of amicus Therapeutics. "In the second half of 2008, we will...

Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease

... CRANBURY, N.J., Aug. 4 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ), a biopharmaceutical... expected to be available by Q1 2009. In addition, amicus expects to conduct clinical pharmacology studies to support the Phase 3 program. amicus is developing Amigal as part of a strategic collab...

Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease

... CRANBURY, N.J., June 3 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ), a biopharmaceutical...irimycin HCl), for the treatment of Pompe disease. amicus will conduct the study in adult Pompe patients in ... to cause the various symptoms of Pompe disease. amicus is initiating the multi-national, open-label Phase...

Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220

...Therapy CRANBURY, N.J., March 13 /PRNewswire/ -- amicus Therapeutics, a biopharmaceutical company developi...T2220," said John F. Crowley, President and CEO of amicus Therapeutics. "Based on these data and the safety ...ingredient in AT2220 in the United States. About amicus Therapeutics ...

Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference

... CRANBURY, N.J., Jan. 2 /PRNewswire-FirstCall/ -- amicus Therapeutics Inc. (Nasdaq: FOLD ), today announce... Company's website until January 22, 2008. About amicus Therapeutics amicus Therapeutics is a biopharmaceutical company develo...

Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease

... CRANBURY, N.J., Oct. 23 /PRNewswire-FirstCall/ -- amicus Therapeutics, a biopharmaceutical company developi...sease," said John F. Crowley, President and CEO of amicus Therapeutics. About Pompe Disease Pompe disease ... ingredient in AT2220 in the United States. About amicus Therapeutics ...
Amicus in Biological Technology

Meredith Martin Addy Named Chair of AIPLA's Amicus Committee

CHICAGO, Nov. 2 /PRNewswire/ -- Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the United States, is pleased to announce that Meredith Martin Addy, a shareholder and chair of the firm's Appellate Group, has been appointed chair of the Amicus Committee of the...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... CRANBURY, N.J., Aug. 5 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced fin.... Generally Accepted Accounting Principles (GAAP), amicus announced a net loss attributable to common stockh...ion. John F. Crowley, President and CEO of amicus stated, "The second quarter was marked by a signif...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date

... CRANBURY, N.J., July 29 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) will announce secon...n also be accessed via the investor section of the amicus Therapeutics Web site at www.amicustherapeutics....l remain available in the Investors section of the amicus Therapeutics Web site for 30 days. Amicus'...

Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009

...CRANBURY, N.J., May 11 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced tha...tion by logging on to the Investors section of the amicus Therapeutics' Web site, http://www.amicustherap...on the Company's Web site for 30 days. About amicus Therapeutics ...

Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date

...CRANBURY, N.J., April 30 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) will announce first...n also be accessed via the investor section of the amicus Therapeutics Web site at www.amicustherapeutics....l remain available in the Investors section of the amicus Therapeutics Web site for 30 days. Amicus' p...

Shire begins the year with a strong performance

...study ongoing. HGT-3510 - for the treatment of Pompe Disease - In February 2009, the Phase 2 clinical trial for HGT-3510 initiated by amicus Therapeutics Inc. ("Amicus") was placed on clinical hold in response to reports of two serious adverse events that were probably related t...

Marinus Pharmaceuticals Raises $20 Million in Series B Financing

...f innovative companies in the digital media, communications & mobility, enterprise and clean tech industries. Among its successes are Acme Packet, amicus Therapeutics, Cerexa Inc., CommerceOne, DexCom Inc., DoubleClick, IntraLinks, Match.com, SuccessFactors and WebLoyalty. Other Canaan investments inclu...

Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference

...CRANBURY, N.J., March 30 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced tha...tion by logging on to the Investors section of the amicus Therapeutics' Web site, www.amicustherapeutics.co...on the Company's Web site for 90 days. About amicus Therapeutics ...

Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting

...CRANBURY, N.J., March 28 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) announced today pos...ients." John F. Crowley, President and CEO of amicus Therapeutics, added, "We are very pleased with thi...econd quarter of this year." In January 2009, amicus announced that the FDA supports a Phase 3 clinical...

Publication of Shire plc's Annual Report 2008

...ely small company's future. Three deals later-with amicus Therapeutics, Inc. ('Amicus'), Zymenex A/S ('Zymen...r 2007 Shire entered into a license agreement with amicus under which it received the rights to three compou...market exclusivity in the EU. In March 2008 amicus announced positive data from its Phase 2 clinical ...
Other Tags
(Date:8/22/2014)... San Jose, CA (PRWEB) August 22, 2014 ... are now offering a new teeth whitening technique. Air ... during regular cleaning appointments. , Dark teeth can be ... into two categories: external stains and internal stains. External ... Internal stains can be caused by certain medications, such ...
(Date:8/22/2014)... found that targeted automated alerts in electronic health ... patients with urinary catheters. In addition, when the ... of improvement dramatically increased. , The alerts help ... in the first place and then alert them ... not been removed within a recommended time period. ...
(Date:8/22/2014)... August 22, 2014 Natural Clear Vision ... to restore his own vision from legally blind to perfect ... an investigative review. , “There is a huge portion ... for everyday function, and most people just think that’s the ... eye surgery that can be pretty risky at times,” reports ...
(Date:8/22/2014)... found in the circulating free tumor DNA (ctDNA) from ... patients correlates well with the EGFR mutations from patient-matched ... therapy is approved for EGFR activating mutation positive patients ... status is with DNA derived directly from tumor tissue, ... abundant and less invasive source of tumor DNA may ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Testosterone ... filed in U.S. courts on behalf of men ... their use of prescription low testosterone therapies, Bernstein ... new claim was filed against Pfizer Inc. on ... suffered life-threatening heart issues due to his use ...
Breaking Medicine News(10 mins):Health News:Japantown Dental Introduces Air Polishing 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4
(Date:8/21/2014)... Despite a significant reduction in smog-producing toxins in ... , A new study shows that while the ... of the toxins that contribute to smog, the ... ozone air pollution., Smog, which can cause or ... chronic bronchitis, is produced by a set of ...
(Date:8/21/2014)... ignore, but they are the ultimate source of all ... increasingly dependent on algae, too, to suck up climate-warming ... the bottom of the ocean. Now, by using a ... evidence showing that viruses infecting those algae are driving ... all else stays essentially the same, and this has ...
(Date:8/21/2014)... Nine researchers from Beth Israel Deaconess Medical Center (BIDMC ... World,s Most Influential Scientific Minds 2014," a comprehensive ... a web resource for science metrics and research performance ... the most influential "are performing and publishing work that ... their science," according to a Thomson Reuters statement. Researchers ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2Viruses take down massive algal blooms, with big implications for climate 2BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3
Other Contents